News

DoKaSch Temperature Solutions announces business expansion in Asia-Pacific region

Due to the strong growth signals in the important pharmaceutical market of South Korea, Kevin Lee has assumed – with immediate effect – the position Sales & Business Development Manager South Korea with DoKaSch Temperature Solutions. Thus, the company...

Schreiner MediPharm’s High-Tech Digital Adherence Monitoring Solution Wins FINAT Award

Schreiner MediPharm, a Germany-based global provider of innovative functional label solutions for the healthcare industry, won a prestigious award for its Smart Blister Card from the European Association of the Self-Adhesive Label Industry (FINAT), which recognizes the industry’s best...

Pharma Targeting launches FMCG Targeting

Pharma Targeting, a leading global pharmaceutical market intelligence and data company, and one of the Targeting Group companies, has today launched FMCG Targeting, a super connector service exclusively for FMCG service providers. The bespoke research house with a backbone of...

Fast biologic sales may see European Pharma cross US Firms

The worldwide pharmaceutical sector is going through a major overhaul that is most definitely going to shape its future. It is estimated that by 2028, European pharma companies are going to leave their US counterparts behind when it comes...

Exploring The Patient’s Journey: A Look At The Onboarding Process

As a healthcare provider, you know how important it is to create a positive experience for your patients from the moment they walk through your doors. One crucial aspect of this experience is the onboarding process.   This is where patients...

Pharma Industry Argues Unconstitutionality In Price-Settings

NICA, PhRMA, and GCCA lodged a complaint in the U.S. District Court for the Western District of Texas, asserting that the price setting provisions outlined in the Inflation Reduction Act infringe upon the Constitution. They argue that these provisions...

Pharma Trade Group Sues US Government On Medicare Drug Costs

On June 21, the pharma sector’s biggest lobbying group, along with two major organisations, went on to sue the Biden administration when it came to the new powers of Medicare to cut medicine prices for seniors as per the...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read